Evidence map›Paper›PMID 40473620›Full record

ArticleNature communications2025

Bio-inspired multifunctional disruptors of calcium oxalate crystallization.

Doyoung Kim, Vraj P Chauhan, Bryan G Alamani, Saxton D Fisher, Zhi Yang, Matthew R Jones, Tanguy Terlier, Peter G Vekilov, Jeffrey D Rimer

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Intercalated bacterial biofilms are intrinsic internal components of calcium-based kidney stones.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Thermodynamics of calcium binding to heparin: Implications of solvation and water structuring for polysaccharide biofunctions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Doyoung Kim *William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, 4226 Martin Luther King Blvd., Houston, TX, 77204-4004, USA.
Vraj P Chauhan *William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, 4226 Martin Luther King Blvd., Houston, TX, 77204-4004, USA.
Bryan G Alamani *William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, 4226 Martin Luther King Blvd., Houston, TX, 77204-4004, USA.ORCID http://orcid.org/0000-0002-6063-8108
Saxton D FisherDepartment of Chemistry, Rice University, Houston, TX, 77005, USA.
Zhi YangDepartment of Chemistry, Rice University, Houston, TX, 77005, USA.ORCID http://orcid.org/0000-0001-5691-6681
Matthew R JonesDepartment of Chemistry, Rice University, Houston, TX, 77005, USA.ORCID http://orcid.org/0000-0002-9289-291X
Tanguy TerlierSIMS laboratory, Shared Equipment Authority, Rice University, 6100 Main Street, 77005, Houston, TX, USA.
Peter G VekilovWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, 4226 Martin Luther King Blvd., Houston, TX, 77204-4004, USA.ORCID http://orcid.org/0000-0002-3424-8720
Jeffrey D RimerWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, 4226 Martin Luther King Blvd., Houston, TX, 77204-4004, USA. jrimer@central.uh.edu.ORCID http://orcid.org/0000-0002-2296-3428

Funding

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary StonesR01DK136684 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI NAIM M MAALOUF · 2023 to 2026
$1.9M
David and Lucile Packard Foundation (David & Lucile Packard Foundation) 2018-68049NIDDK NIH HHS R01 DK136684Welch Foundation C-2146Welch Foundation E-1794Welch Foundation E-2170Welch Foundation V-E-0001
6 · The paper itself

Abstract

Calcium mineralization in biological and geological systems is often regulated by (macro)molecules enriched with anionic functional moieties. Relatively few studies have examined the effects of phosphate-based modifiers that are integral in calcification underlying human bone formation and pathological diseases. Here we mimic posttranslational phosphorylated moieties of a biologically-active inhibitor protein and demonstrate that polyphosphates and phosphonates suppress calcium oxalate nucleation, tailor solvate crystal structure, and irreversibly inhibit crystal growth in ways that significantly deviate from commonly investigated carboxylate-rich modulators of biomineralization. The most potent modifiers exhibit an uncommon dual mode of action, wherein nucleation is suppressed by altering prenucleation clusters and crystal surface growth is impeded irreversibly by inducing lattice strain. Once crystal surfaces are exposed to modifiers, recrystallization is severely restricted. This exemplifies the uniqueness and efficiency of phosphates wherein their multiple modes of action are promising characteristics for designing de novo biologically-inspired molecules as mineralization regulators.

Indexed as

Calcium OxalateBiomineralizationCrystallizationHumansOrganophosphonatesPhosphatesCalcium OxalateOrganophosphonatesPhosphates

Identifiers

PMID40473620
PMCPMC12141576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.